Home A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma)
Article
Licensed
Unlicensed Requires Authentication

A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma)

  • Ifra Abdul Qaiyyum , Mohammad Nawab ORCID logo EMAIL logo and Munawwar Husain Kazmi
Published/Copyright: September 29, 2021

Abstract

Objectives

Kalaf (Melasma) is an acquired facial hypermelanism. It has direct impact on patient’s quality of life and leads to development of various personality disorders. Lack of effective treatment and recurrences have drawn the attention of researcher to find alternative treatment. This study aimed to evaluate safety and efficacy of a topical Unani formulation in the management of melasma.

Methods

We conducted a prospective randomized controlled clinical study on the participants diagnosed with melasma. The participants (n=72) randomized into test (n=36) and control (n=36) groups. Sixty participants (n=30 in each group) completed the duration of therapy. The participants of the test group were treated with a classical Unani formulation and control group with hydroquinone 4%. The primary end point was change in mean MASI score and secondary end point was improvement in quality of life after eight weeks of treatment.

Results

The Unani formulation reduced 40.5% mean MASI score (17.31 ± 9.58 to 10.28 ± 5.92) in comparison to 32% reduction in mean MASI score (20.58 ± 9.49 to 13.92 ± 7.38) in the control group after eight weeks of treatment. When comparing with baseline the difference in MASI score was found statistically significant in both groups (p<0.05). On intergroup comparison, the change in MASI score between both groups was not statistically significant (p>0.05). In addition, MQOL and DQLI also improved significantly in both groups.

Conclusions

This study concluded that the Unani formulation and the control drug were equally effective and safer in the management of melasma.


Corresponding author: Mohammad Nawab, MD (Moalajat), Reader, Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders, Erragadda, 500038 Hyderabad, Telangana, India, E-mail:

Funding source: Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, New Delhi

Award Identifier / Grant number: An Academic Trial

Acknowledgments

Authors are thankful to the Director General, Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, New Delhi for providing financial support and resource materials for the study.

  1. Research funding: This work was funded by Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, New Delhi as an academic trial.

  2. Author contributions: Ifra Abdul Qaiyyum developed protocol, collected and recorded data and drafted manuscript. Mohammad Nawab developed protocol, analyzed, interpreted data and edited the manuscript. M.H. Kazmi analyzed the data and vetted the manuscript.

  3. Competing interests: Authors declare that there is no conflict of interest. The funding organization played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report or in the decision to submit the report for publication.

  4. Honorarium: None declared.

References

1. Bagherani, N, Gianfaldoni, S, Smoller, B. An overview on melasma. J Pigment Disord 2015;2:1–18. https://doi.org/10.4172/2376-0427.1000216.Search in Google Scholar

2. Coban, M. Quality of life of the patients with melasma. J Cosmetol Trichol 2018;4:1–4. https://doi.org/10.4172/2471-9323.1000133.Search in Google Scholar

3. Kristlova, H. Melasma in men. J Pigment Disord 2014;S1:004. https://doi.org/10.4172/JPD.S1-004.Search in Google Scholar

4. Sarkar, R, Arora, P, Garg, VK, Sonthalia, S, Gokhale, N. Melasma update. Indian Dermatol Online J 2014;5:426–35. https://doi.org/10.4103/2229-5178.142484.Search in Google Scholar PubMed PubMed Central

5. Bandyopadhyay, D. Topical treatment of melasma. Indian J Dermatol 2009;54:303–9. https://doi.org/10.4103/0019-5154.57602.Search in Google Scholar PubMed PubMed Central

6. Kaliterna, D, Zuzul, K, Kovacevic, I. Melasma-review of current treatment modalities and efficacy assessment of a new resorcinol-based topical formulation. J Clin Cosmet Dermatol 2017;1:1–4. https://doi.org/10.16966/2576-2826.116.Search in Google Scholar

7. LeBon, B, Beynon, TA, Whittaker, SJ. Referral to palliative care services can be encouraged at any stage of the disease to optimize symptom control outcomes. World Health 2007;325:330.Search in Google Scholar

8. Shankar, K, Godse, K, Aurangabadkar, S, Lahiri, K, Mysore, V, Ganjoo, A, et al.. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther 2014;4:165–86. https://doi.org/10.1007/s13555-014-0064-z.Search in Google Scholar PubMed PubMed Central

9. Sarkar, R, Puri, P, Jain, RK, Singh, A, Desai, A. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol 2010;24:768–72. https://doi.org/10.1111/j.1468-3083.2009.03524.x.Search in Google Scholar PubMed

10. Achar, A, Rathi, SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol 2011;56:380–2. https://doi.org/10.4103/0019-5154.84722.Search in Google Scholar PubMed PubMed Central

11. Handel, AC, Miot, LDB, Miot, HA. Melasma: a clinical and epidemiological review. An Bras Dermatol 2014;89:771–82. https://doi.org/10.1590/abd1806-4841.20143063.Search in Google Scholar PubMed PubMed Central

12. Hexsel, D, Lacerda, DA, Cavalcante, AS, Filho, CA, Kalil, CL, Ayres, EL, et al.. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol 2014;53:440–4. https://doi.org/10.1111/j.1365-4632.2012.05748.x.Search in Google Scholar PubMed

13. Sarkar, R, Ailawadi, P, Garg, S. Melasma in men: a review of clinical, etiological, and management issues. J Clin Aesthetic Dermatol 2018;11:53–9.Search in Google Scholar

14. Yalamanchili, R, Shastry, V, Betkerur, J. Clinico-epidemiological study and quality of life assessment in melasma. Indian J Dermatol 2015;60:519. https://doi.org/10.4103/0019-5154.164415.Search in Google Scholar PubMed PubMed Central

15. Arora, P, Sarkar, R, Garg, VK, Arya, L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthetic Surg 2012;5:93–103. https://doi.org/10.4103/0974-2077.99436.Search in Google Scholar PubMed PubMed Central

16. D’Mello, SA, Finlay, GJ, Baguley, BC, Askarian-Amiri, ME. Signaling pathways in melanogenesis. Int J Mol Sci 2016;17:1144. https://doi.org/10.3390/ijms17071144.Search in Google Scholar PubMed PubMed Central

17. Latif, A, Zafer, N, Abdullah. Randomized clinical trial of Unani formulations in melasma/chloasma. Hippocratic J Unani Med 2012;7:19–31.Search in Google Scholar

18. Arora, P, Meena, N, Sharma, PK, Raihan, M. Impact of melasma on quality of life in Indian patients. Pigment Int 2017;4:92–7. https://doi.org/10.4103/2349-5847.219683.Search in Google Scholar

19. Jiang, J, Akinseye, O, Tovar-Garza, A, Pandya, AG. The effect of melasma on self-esteem: a pilot study. Int J Wom Dermatol 2018;4:38–42. https://doi.org/10.1016/j.ijwd.2017.11.003.Search in Google Scholar PubMed PubMed Central

20. Ogbechie-Godec, OA, Elbuluk, N. Melasma: an up-to-date comprehensive review. Dermatol Ther 2017;7:305–18. https://doi.org/10.1007/s13555-017-0194-1.Search in Google Scholar PubMed PubMed Central

21. Anonymous. Qarabaddin-e- Azam-Wo-Akmal. New Delhi: Central Council for Research in Unani Medicine; 2005:395 p.Search in Google Scholar

22. Sealed Envelope Ltd. Create a blocked randomisation list; 2021. https://sealedenvelope.com/simple-randomiser/v1/lists [Accessed 19 Mar 2021].Search in Google Scholar

23. Faul, F, Erdfelder, E, Lang, AG, Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–91.10.3758/BF03193146Search in Google Scholar

24. Theplantlist. The plant list, 2013 version 1.1; 2021. http://www.theplantlist.org/ [Accessed 19 Mar 2021].Search in Google Scholar

25. Kavya, M. Melasma: a clinico-epidemiological study. Int J Basic Appl Med Sci 2014;4:388–91.Search in Google Scholar

26. Pichardo, R, Vallejos, Q, Feldman, SR, Schulz, MR, Verma, A, Quandt, SA, et al.. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009;48:22–6. https://doi.org/10.1111/j.1365-4632.2009.03778.x.Search in Google Scholar PubMed PubMed Central

27. Sultana, A, Siddiquee, MR, Khanna, N, Ahmad, T, Shiffa, M. Comparative clinical evaluation of Unani formulations in the treatment of melasma. Am J PharmTech Res 2012;2:759–69.Search in Google Scholar

28. Karrabi, M, David, J, Sahebkar, M. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman’s formula in subjects with epidermal melasma: a randomized, double-blind clinical trial study. Skin Res Technol 2020;27:24–31. https://doi.org/10.1111/srt.12901.Search in Google Scholar PubMed

29. Khosravan, S, Alami, A, Moghadam, MH, Ramezani, V. The effect of topical use of petroselinum crispum (parsley) vs. that of hydroquinone cream on reduction of epidermal melasma-a randomized clinical trial. Holist Nurs Pract 2017;31:16–20. https://doi.org/10.1097/HNP.0000000000000186.Search in Google Scholar PubMed

30. McKesey, J, Garza, AT, Pandya, AG. Melasma treatment: an evidence based review. Am J Clin Dermatol 2020;21:173–225. https://doi.org/10.1007/s40257-019-00488-w.Search in Google Scholar PubMed

31. Kirtikar, KR, Basu, BD. Indian medicinal plants. Dehradun: International Book Distribution; 1918:1420–3 pp.10.5962/bhl.title.137025Search in Google Scholar

32. Ghani, NM. Khazainul Advia. Lahore (Pakistan): Idara Matbuat-i- Sulemani; 1998:171–4, 437–40, 273–6, 255–7 pp.Search in Google Scholar

33. Arora, P, Meena, N, Sharma, PK, Raihan, M. Impact of melasma on quality of life in Indian patients. Pigment Int 2017;4:92–7. https://doi.org/10.4103/2349-5847.219683.Search in Google Scholar

Received: 2021-08-10
Accepted: 2021-09-21
Published Online: 2021-09-29

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Does acupuncture improve sexual dysfunction? A systematic review
  4. Non-alcoholic fatty liver disease – discussed under the light of Unani medicine
  5. Phytochemistry and pharmacology of Celastrus paniculatus Wild.: a nootropic drug
  6. Low back pain patients’ perceived effectiveness of utilizing complementary and alternative medicine: a systematic review of qualitative studies
  7. Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials
  8. Research Articles
  9. Psychobiotic interventions attenuate chronic alcohol use-mediated exacerbation of posttraumatic stress disorder in rats: the role of gut-liver axis response
  10. Evaluation of the toxicity of crude aqueous Pleurotus tuber-regium (Fr.) Singer extract in mice
  11. Effects of crude methanol extract of Adansonia digitata fruit pulp on Naja nigricollis venom-induce toxicity in Wistar rats
  12. Integrative medicine approaches to chronic depression: case studies of the recovery process with a three-step path to recovery and significant cure
  13. Antimicrobial, anti-adhesion, anti-biofilm properties of goji berry (Lycium barbarum) against periodontal bacteria: potential benefits for periodontal diseases
  14. Method development and validation for quantification of six bioactive compounds (andrographolide, columbin, piperine, gallic, paracoumaric and oleanolic acids) by HPTLC
  15. Gallic acid a flavonoid isolated from Euphorbia hirta antagonizes gamma radiation induced radiotoxicity in lymphocytes in vitro
  16. Naturopathic knowledge and approaches to managing endometriosis: a cross-sectional survey of naturopaths with experience in endometriosis care
  17. Halimeda gracilis (Kadarpassi chooranam) Phytochemical analysis and biological significance – a novel Siddha drug
  18. Trends in the St. John’s wort (Hypericum perforatum) research literature: a bibliometric analysis
  19. Use and perception of complementary and alternative medicine among Iranian psychologists
  20. Innovative histological and histochemical characterization of tongue biopsies from patients with burning mouth syndrome
  21. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women
  22. Comparing the influence of foot reflexology and fasting mimicking diet on quality of life and sleep quality in obesity hypoventilation syndrome
  23. The effects of Cynodon dactylon (Poaceae family) and Dolichos biflorus (Fabaceae family) extracts on decreasing size and excretion of kidney and urinary tract stones: a randomized, double-blind controlled trial
  24. Role of Bifidobacterium spp. intake in improving depressive mood and well-being and its link to kynurenine blood level: an interventional study
  25. A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma)
  26. Impact of yoga and physical exercise on psychological wellbeing among substance abusers: a randomized controlled trial
  27. A non-inferiority randomized controlled clinical trial comparing Unani formulations and PUVAsol in non-segmental vitiligo
  28. Efficacy of individualized homeopathic medicines in primary dysmenorrhea: a double-blind, randomized, placebo-controlled, clinical trial
  29. A comparative study of chemical constituents and safety of Thai herbal medicated oil formula and traditional medicated oil
  30. Efficacy of Ayurvedic treatment protocol in gouty arthritis – a clinical study
  31. Knowledge, attitude and perception of complementary and alternative system of medicine in Tamilnadu and Pudhucherry, South India
  32. Discussion Forum
  33. Time to say good-bye? Homeopathy, skeptics and thoughts on how to proceed
  34. Congress Abstracts
  35. 2022 INCAM Research Symposium
Downloaded on 2.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2021-0353/html
Scroll to top button